Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia.
Krieger, E; Kudryavtsev, A; Sharashova, E; Postoev, V; Belova, N; Shagrov, L; Zvedina, J; Drapkina, O; Kontsevaya, A; Shalnova, S; +4 more...Brenn, T; Shkolnikov, VM; Eggo, RM
; Leon, DA and
(2022)
Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia.
EMERGING INFECTIOUS DISEASES, 28 (2).
pp. 463-465.
ISSN 1080-6040
DOI: 10.3201/eid2802.211640
; Leon, DA and
(2022)
Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia.
EMERGING INFECTIOUS DISEASES, 28 (2).
pp. 463-465.
ISSN 1080-6040
DOI: 10.3201/eid2802.211640
Population-based data on coronavirus disease in Russia and on the immunogenicity of the Sputnik V vaccine are sparse. In a survey of 1,080 residents of Arkhangelsk 40-75 years of age, 65% were seropositive for IgG. Fifteen percent of participants had been vaccinated; of those, 97% were seropositive.
-
picture_as_pdf - Krieger_etal_2022_Seroprevalence-of-SARS-Cov-2-Antibodies.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution 4.0
Downloads